SABATINI BRENT (SVP, Chief Accounting Officer) sold 0.6% of their position (379.00 shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $3.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001628280-26-039938
Officer· SVP, Chief Accounting Officer
Since Feb 2026
-379.00
Net shares
Net seller
$3.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
379.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−379.00
Price / share
$9.45
Trade value
$3.58K
% of position
0.6%
6/1/2026
62.28K→61.90K
Total
Net shares
−379.00
Net value
-$3.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −379.00 | $9.45 | $3.58K | 0.6% | 62.28K | 61.90K |
| Total | −379.00 | -$3.58K | ||||||
Derivative Transactions0
No derivative transactions reported